bluebird bio Inc (NAS:BLUE)
$ 0.9764 0.073 (8.08%) Market Cap: 187.58 Mil Enterprise Value: 303.88 Mil PE Ratio: 0 PB Ratio: 0.47 GF Score: 25/100

Q2 2021 bluebird bio Inc Earnings Call Transcript

Aug 09, 2021 / 12:00PM GMT
Release Date Price: $11.76 (-27.45%)
Operator

Good day and thank you for standing by. Welcome to the Bluebird Bio Second Quarter 2021 Earnings Conference Call. (Operator Instructions)

Please be advised that today's conference is being recorded.

Now I would like to hand the conference over to your first speaker for today, Ms. Liz Pingpank. Please go ahead.

Elizabeth Pingpank
bluebird bio, Inc. - Director of Corporate Communications

Good morning, everyone, and thank you for joining today's call to discuss our second quarter results and associated business updates. The press release announcing these updates can be found on the Investor Relations section of our website.

Before we begin, let me review our safe harbor statement. Today's discussion contains statements that are forward looking under the Private Securities Litigation Reform Act of 1995, including financial projections in addition to statements of the company's plans, expectations or intentions regarding development of our clinical programs. Such statements are based on current expectations and assumptions that are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot